USE OF BLOOD COMPONENTS IN EXTRACORPOREAL MEMBRANE OXYGENATION (ECMO)-TREATED PATIENTS WITH COVID-19
VF Dutra, APH Yokoyama, DL Rocha, BA Bravim, GFJ Matos, TD Correa, JM Kutner
Hospital Israelita Albert Einstein (HIAE), São Paulo, SP, Brazil
Lido
835
Vezesque se leu este artigo
354
Total PDF
481
Total HTML
| Ano/Mês | Html | Total | |
|---|---|---|---|
| 2025 6 | 21 | 7 | 28 |
| 2025 5 | 47 | 12 | 59 |
| 2025 4 | 30 | 10 | 40 |
| 2025 3 | 40 | 9 | 49 |
| 2025 2 | 24 | 11 | 35 |
| 2025 1 | 24 | 23 | 47 |
| 2024 12 | 20 | 9 | 29 |
| 2024 11 | 22 | 18 | 40 |
| 2024 10 | 16 | 19 | 35 |
| 2024 9 | 22 | 23 | 45 |
| 2024 8 | 23 | 13 | 36 |
| 2024 7 | 26 | 23 | 49 |
| 2024 6 | 18 | 24 | 42 |
| 2024 5 | 21 | 27 | 48 |
| 2024 4 | 19 | 15 | 34 |
| 2024 3 | 28 | 27 | 55 |
| 2024 2 | 26 | 27 | 53 |
| 2024 1 | 30 | 13 | 43 |
| 2023 12 | 14 | 26 | 40 |
| 2023 11 | 7 | 11 | 18 |
| 2023 10 | 3 | 7 | 10 |
Mostrar tudo
